by Simon Casey
Monsanto shares surged after the Wall Street Journal reported that the U.S. Department of Justice decided to approve its $66 billion takeover by Bayer AG, removing the last major regulatory obstacle to the completion of the biggest deal in the seeds and crop-chemicals industry.
An agreement in principle has been brokered between the two companies in recent days, the newspaper reported, citing people familiar with the matter. That marks a breakthrough for the review process, as just last month, Justice Department officials weren’t satisfied with Bayer’s plan because of concerns that the transaction could hurt competition, two people familiar with the matter told Bloomberg News at the time.
Bayer’s proposed takeover of St. Louis-based Monsanto is part of a wave of consolidation that has swept seed and crop-chemical firms in the past three years. Two previous deals, the combination of Dow Chemical Co. and DuPont Co. and China National Chemical Corp.’s takeover of Syngenta AG, won antitrust clearance.
Bayer, which is based in Leverkusen, Germany, has previously agreed to sell seed-and-agrochemical assets to BASF SE for $7 billion. BASF is also in talks to buy Bayer’s vegetable seed business.
In its review of the Bayer-Monsanto merger, the Justice Department is looking at horizontal antitrust issues, or competition in the same market, as well as vertical competition, or issues along supply chains, one of the people said.
A spokeswoman for Monsanto and a Bayer spokesman both declined to comment on the WSJ report. Monsanto said last week that the deal will be wrapped up by June.
Monsanto rose as much as 7.6% to $126.80 in New York trading. Bayer’s all-cash deal values the company at $128 a share.
--With assistance from Naomi Kresge and Lydia Mulvany.
To contact the reporter on this story: Simon Casey in New York at [email protected]
To contact the editors responsible for this story: Simon Casey at [email protected]
© 2018 Bloomberg L.P